Lawesson's reagent → HCID 86718511, compound
Reaction equation
[CH3:1][C:2]1([CH3:14])[CH2:8][C:7](=O)[NH:6][C:5]2[CH:10]=[CH:11][CH:12]=[CH:13][C:4]=2[NH:3]1.COC1C=CC(P2(SP(C3C=CC(OC)=CC=3)(=S)S2)=[S:24])=CC=1>C1COCC1>[CH3:1][C:2]1([CH3:14])[CH2:8][C:7](=[S:24])[NH:6][C:5]2[CH:10]=[CH:11][CH:12]=[CH:13][C:4]=2[NH:3]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 80 °C
Procedure
A disposable tube was charged with 4,4-dimethyl-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one (697 mg, 3.66 mmol) in THF (20 mL). Lawesson's Reagent (815 mg, 2.015 mmol) was added, and the solution was stirred at 80° C. for 3 h. The solution was concentrated, partitioned between water and ethyl acetate, separated, dried with sodium sulfate, concentrated with celite, and purified by silica gel chromatography to yield 4,4-dimethyl-4,5-dihydro-1H-benzo[b][1,4]diazepine-2(3H)-thione as a yellow oily solid (0.60 g, 2.91 mmol, 79%).
Workup
- concentrationThe solution was concentrated
- custompartitioned between water and ethyl acetate
- customseparated
- dry with materialdried with sodium sulfate
- concentrationconcentrated with celite
- custompurified by silica gel chromatography
Sources & evidence
- ORD record
- ord-af8dd2ec25434f8fa6b98e61193d3722
- Source dataset
- uspto-grants-2016_08
- Patent number
- US09422292B2
Reaction notes
Loading…